Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Randomized Double-blind Placebo-controlled Study to Evaluate the Effect of Rosuvastatin in Diabetic Polyneuropathy

NCT01622777 is registered in ClinicalTrials.gov with Alejandra Guillermina Miranda Diaz as lead sponsor.

NCT NCT01622777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01622777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Randomized Double-blind Placebo-controlled Study to Evaluate the Effect of Rosuvastatin in Diabetic Polyneuropathy
Lead sponsor
Alejandra Guillermina Miranda Diaz
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
June 30, 2011
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic polyneuropathy